![Open Access](/resources/images/iconopenaccess.png)
Multiple large xanthomas: A case report
- Authors:
- Published online on: October 18, 2016 https://doi.org/10.3892/ol.2016.5282
- Pages: 4327-4332
-
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Abstract
Introduction
A xanthoma refers to an exogenous mass that is visible on the body surface. Xanthomas are not tumors but clusters of foam cells that form within the connective tissue of the skin, tendons and subcutaneous tissues. Xanthomas comprise important clinical manifestations of lipid metabolism disorders, and are commonly encountered in patients with familial hypercholesterolemia (FH) (1). Xanthomas may be divided into several categories: Tendinous xanthoma, xanthoma tuberosum, eruptive xanthoma, xanthoma planum and palmar xanthoma (1). The most commonly observed xanthomas among patients with FH are tendinous xanthomas (40–50% of all patients), which are subcutaneous tumors located within the tendons used for extension, and mainly affect the Achilles, patellar tendons and extensor tendons of the hands, buttocks, elbows, eyelids and hand creases (2,3). Tuberous xanthomas are also commonly observed in FH patients (10–15% of all patients), and manifest as yellow nodules, often measuring ≤2 cm in diameter, and are located in pressure areas, including the extensor aspects of the knees, elbows and buttocks (2–4). The clinical manifestations associated with xanthomas depend on the duration and severity of hyperlipoproteinemia (5); therefore, the presence of multiple xanthomas often indicates severe and long-term FH and tends to be observed in patients with homozygous FH (HoFH) (2,6).
FH is an inherited disorder featuring elevated plasma levels of low-density lipoprotein cholesterol (LDLC), atherogenesis and xanthomas (7). Two clinical variants of this disorder exist, the homozygous and heterozygous variants. Heterozygous FH (HeFH) accounts for the majority of FH cases, with an approximate incidence of 1 per 500 individuals; whereas the homozygous variant of the disease is considerably rare, with an approximate incidence of 1 per 1,000,000 individuals (3). The clinical features of HeFH are mild, and include a blood LDLC concentration of >4.9 mmol/l, total cholesterol (TC) levels >7.5 mmol/l and an age of onset of >20 years (8). By contrast, HoFH is characterized by a greater incidence rate of cutaneous xanthomas, enlarged Achilles tendons, atherosclerosis, corneal arcus, a blood LDLC concentration of >13 mmol/l, TC levels >14.95 mmol/l and disease onset in early childhood (7).
The present study reports the case of a 23-year-old male patient with HoFH, who presented with multiple large tuberous and tendinous xanthomas within various dermal tissues.
Case report
A 23-year-old male patient presented at Zhejiang Provincial People's Hospital (Hangzhou, China) in May 2008 with multiple yellowish elevated masses over the dorsum of the elbows, knees, buttocks and hands. The size of the masses varied between 1×1×1 cm (over the dorsum of the hands) and 7×5×4 cm (over the dorsum of the elbows) (Fig. 1). The lesions were originally asymptomatic; they appeared at 2 years of age and then progressively increased in size and extent. The patient had symptoms of discomfort and pain in the elbows and buttocks, which were due to the large size of the masses.
The plasma TC levels of the patient were 14.95 mmol/l (reference value, 3.11–5.96 mmol/l), whereas the LDLC level was 12.69 mmol/l (reference value, 2.10–3.10 mmol/l). The apolipoprotein (Apo) A1 level was 0.74 g/l (reference value, 1.10–1.76 g/l), the Apo B level 2.84 g/l (reference value, 0.63–1.14 g/l) and the Apo A1/Apo B ratio was 3.84 (reference value, 0.40–1.96). Test results for liver enzymes, renal function, blood glucose, uric acid, free thyroxin and thyroid-stimulating hormone were normal. A Doppler ultrasound scan (TA700; Toshiba, Tokyo, Japan) revealed that the two carotid arteries and the lower extremity arteries presented with progressive atherosclerosis (Fig. 2). The carotid arteries had accumulated atheromatous plaques, and the lower extremity arteries had progressive calcific sclerosis. Patient chest X-ray, abdominal ultrasound, electrocardiogram and echocardiogram were normal. Magnetic resonance imaging (MRI) scans (Siemens AG, Munich, Germany) revealed decreased signal intensity on T1-weighted and T2-weighted spin-echo images of the masses in the elbows, knees and posterior malleolus. Xanthomas had infiltrated the triceps tendon and the patellar ligament. MRI scan also revealed a thickened Achilles tendon and patellar ligament (Fig. 3). Neurological examination for central nervous system function and brain MRI scan were performed to determine the presence or absence of cerebrotendinous xanthomatosis (9), a rare autosomal-recessive familial lipid metabolic disease caused by mutations in sterol 27 hydroxylase; however, no abnormality was identified.
The father of the patient had a history of coronary heart disease (CHD) and was treated with percutaneous coronary intervention 2 years previously. The mother and sister had no reported symptoms of CHD or similar skin lesions. The two parents demonstrated elevated TC and LDLC levels, a typical characteristic of HeFH, whereas the sister did not. Secondary hypercholesterolemia, which may be caused by hypothyroidism, diabetes and renal or hepatic disease, were excluded. The lipid profiles of the patient and his family are described in Table I.
The patient was diagnosed with HoFH and multiple xanthomas. The patient subsequently abstained from alcohol and tobacco use, and followed a vegetarian diet that was low in saturated fat and cholesterol, as advised by physicians. In addition, the patient was treated with a combined treatment regimen of rosuvastatin (10 mg/day) and ezetimibe (10 mg/day) for a year. Following a year of conservative treatment, no marked decrease in the plasma TC levels (controlled at 13.05 mmol/l) or substantial regression of the multiple xanthomas was observed. Due to the symptomatic nature of the lesions and for cosmetic reasons, surgical removal of the large xanthomas was considered necessary. Surgical excision of the masses over the elbows and buttocks was performed. Intraoperatively, the yellowish xanthomatous masses in each elbow were found to closely adhere to the triceps tendon, which prevented the complete excision of these lesions. Excision was not performed for all lesions, since the extent of xanthomatous involvement had not been clearly determined. Resected tissues were sent to the Department of Pathology, Zhejiang Provincial People's Hospital for tissue examination. Microscopic examination of the surgical specimens (Olympus BX50; Olympus Corporation, Tokyo, Japan) revealed nests composed of xanthoma tissue, which consisted of connective tissue and foam cells, containing cholesterol, cholesterol esters, triglycerides and phospholipids (Fig. 4A). These findings confirmed the diagnosis of HoFH. Immunohistochemical staining showed that the foam cells strongly expressed cluster of differentiation 68 (CD68) (Fig. 4B). Treatment with rosuvastatin and ezetimibe was continued postoperatively, and the dose of rosuvastatin was adjusted to 20 mg/day. Four weeks subsequent to surgery, the symptoms had largely resolved. At that point, apheresis therapy was recommended for a better control of the high LDLC levels, but the patient declined due to the high cost of the procedure. Although the patient had no symptoms of CHD, he was advised to take note of any chest tightness and other symptoms of CHD and undergo a cardiac examination at least twice a year. One year following surgery, the serum LDLC levels of the patient were controlled at 8.50 mmol/l with no symptoms of CHD or postoperative recurrence of xanthomas.
Written informed consent was obtained from the patient for the publication of this study, and the study was approved by the Ethics Review Committee of Zhejiang Provincial People's Hospital.
Discussion
Xanthomas are palpable masses that are typically located within the skin or subcutaneous tissue and consist of cholesterol, cholesterol esters, triglycerides, phospholipids, and numerous lipid-laden foamy macrophages (10). Xanthomas have been indicated to commonly occur in patients with FH (1). A previous study has shown that the most frequent site for xanthomas is the Achilles tendon (11). Other frequent sites include the extensor tendons of the hands and feet, as the extensor tendon areas are subject to mechanical stress (11). The mechanical stress encountered in tendons is similar to recurrent trauma, which is thought to predispose these sites to the development of xanthomas (12). Courtice (13,14) indicated that the concentration of LDLs increased in the lymphatic drainage system of a rabbit paw that was subjected to mild heat injury of the skin. Courtice also argued that increased capillary permeability to various subclasses of LDL resulted in an increased extravascular LDL concentration, and that a portion of the extracellular LDL may move into the lymphatic system, which is responsible for draining the area of the paw. Mechanical stress, similarly to the effect of mild heat injury to the skin, also increases capillary permeability around the mechanical stress-exposed areas, which may lead to the accumulation of LDLC. This theory may explain why tuberous xanthomas are predominantly encountered in mechanical stress-exposed regions.
The present patient presented with multiple xanthomas in the mechanical stress-exposed parts of the body, including the buttocks, extensor aspect of the knee, elbow and ankle. The occurrence of multiple large xanthomas is rare. Although the appearance is similar to tumors, xanthomas have distinct characteristics that allow for the differentiation of the two. In the majority of cases, xanthomas are asymptomatic; unless they grow to be large in size and cause compression to adjacent structures, which may cause pain and mobility problems. Histologically, xanthomas consist of foamy macrophages with fibrosis and cholesterol clefts. A high level of LDLC is the most common clinical manifestation and the main cause of xanthomas in patients with FH. In these patients, markedly elevated LDLC levels are secondary to LDL receptor defects and result in lipid leakage from the vasculature into the surrounding tissue. This results in the uptake of lipids by macrophages, which, in turn, leads to the increased accumulation of undegraded lipids and formation of foam cells (1,15). Extracellular cholesterol crystallizes into clefts, inducing an inflammatory reaction with giant cells and resulting in fibrosis. CD68 is particularly useful as a marker for the various cells of the macrophage lineage, including monocytes, histiocytes, giant cells, Kupffer cells and osteoclasts (16). In addition, foam cells, which are widely prevalent in xanthomas, are strongly immunopositive for CD68 (16).
Numerous types of imaging examinations aid the diagnosis of xanthomas. Sonography is a simple, widely available and economical modality used for the identification of xanthomatosis, rendering it superior to gross clinical assessment. Sonography has been reported as an effective method for the investigation of tendinous xanthomas (17,18). In the present case, Doppler ultrasound revealed multiple hypoechoic foci in the masses of each elbow.
An MRI scan is a practical imaging modality that distinguishes xanthomas from tumors. On an MRI scan, xanthomas exhibit morphological and signal intensity abnormalities. In the presence of a xanthoma, the normally flat or concave margins of tendons or other normal tissues may change and appear convex on axial MR images (11). Furthermore, tendons with xanthomas tend to a have increased signal intensity on T1- and T2-weighted spin-echo images compared with normal tendons (19). Tumors often exhibit a marked increase in signal intensity compared with xanthomas.
The patient in the present study presented with multiple large xanthomas with a wide-ranging distribution, and an onset at 2 years of age. The patient had an LDLC level of 12.69 mmol/l, suggesting a high likelihood of HoFH. The parents of the patient had mildly elevated levels of LDLC (father, 5.41 mmol/l; mother, 6.45 mmol/l), which, when combined with the absence of xanthomas, suggests that the parents suffered from HeFH. The patient was the offspring of two parents with HeFH, and appeared to have inherited an HoFH phenotype associated with an increased level of serum LDLC and more severe symptoms than the parents (Fig. 5).
A high level of plasma LDLC is a risk factor for atherosclerosis. Tendinous and tuberous xanthomas may indicate FH and increased cardiovascular risk, as xanthomas are associated with elevated plasma concentrations of LDLC. The presence of xanthomas increases the risk of cardiovascular disease in patients with FH by as much as three-fold, indicating that xanthomas and atherosclerosis may share a certain etiology (20,21). However, cardiovascular disease caused by atherosclerosis in individuals with HoFH typically appears during childhood and may result in mortality by 20–30 years of age (3). Measuring the intima-media thickness by ultrasound aids the identification of the preclinical stages of atherosclerosis (22). In addition, large-scale epidemiological studies have shown an association between increased intima-media thickness and future CHD and stroke (22,23). In the present case, ultrasound showed an increase in the intima-media thickness of the bilateral internal carotid and femoral arteries, indicating FH, and a high risk of developing cardiovascular disease.
The management of patients with HoFH poses a medical challenge. If left untreated, and occasionally despite maximum medical therapy, HoFH often rapidly leads to atherosclerotic changes that cause aortic stenosis and coronary artery disease (24). The first step for the treatment of HoFH is a change in lifestyle and diet regulation. The diet of HoFH patients must be low in saturated fats and cholesterol (8,25). Combined drug therapy, including statins plus ezetimibe or bile acid resin, is recommended for patients with severe hypercholesterolemia (1,26). Studies have shown that statins have the ability to soften xanthomas (1,27). Massive xanthomas may require surgical intervention (28). Surgery is only suggested for xanthomas that are extremely large and painful and cause mobility problems. Certain studies, however, have reported a high postoperative recurrence rate of xanthomas (29). Postoperative cholesterol-lowering therapy may reduce the likelihood of recurrence (27); therefore, for multiple, massive tendinous and tuberous xanthomas, local surgical excision combined with postoperative cholesterol-lowering therapy appears to be the most effective treatment option.
Acknowledgements
The present study was supported by a grant awarded to Professor Qing Bi by the Medical Science and Technology Project In Zhejaing Province (grant no. Y2012ZDA003).
References
Zak A, Zeman M, Slaby A and Vecka M: Xanthomas: Clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 158:181–188. 2014.PubMed/NCBI | |
Sethuraman G, Sugandhan S, Sharma G, Chandramohan K, Chandra NC, Dash SS, Komal A and Sharma VK: Familial homozygous hypercholesterolemia: Report of two patients and review of the literature. Pediatr Dermatol. 24:230–234. 2007. View Article : Google Scholar : PubMed/NCBI | |
Alves C and Braid Z: Homozygous familial hypercholesterolemia: Case report of a rare cause of dyslipidemia. Pediatr Endocrinol Diabetes Metab. 17:162–165. 2011.PubMed/NCBI | |
Cruz PD Jr, East C and Bergstresser PR: Dermal, subcutaneous and tendon xanthomas: Diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 19:95–111. 1988. View Article : Google Scholar : PubMed/NCBI | |
Maher-Wiese VL, Marmer EL and Grant-Kels JM: Xanthomas and the inherited hyperlipoproteinemias in children and adolescents. Pediatr Dermatol. 7:166–173. 1990. View Article : Google Scholar : PubMed/NCBI | |
Moyle M and Tate B: Homozygous familial hypercholesterolaemia presenting with cutaneous xanthomas: Response to liver transplantation. Australas J Dermatol. 45:226–228. 2004. View Article : Google Scholar : PubMed/NCBI | |
Raal FJ and Santos RD: Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment. Atherosclerosis. 223:262–268. 2012. View Article : Google Scholar : PubMed/NCBI | |
Poustie VJ and Rutherford P: Dietary treatment for familial hypercholesterolaemia. Cochrane Database Syst Rev. 2001:CD0019182001. | |
Moghadasian MH: Cerebrotendinous xanthomatosis: Clinical course, genotypes and metabolic backgrounds. Clin Invest Med. 27:42–50. 2004.PubMed/NCBI | |
Szalat R, Arnulf B, Karlin L, Rybojad M, Asli B, Malphettes M, Galicier L, Vignon-Pennamen MD, Harel S, Cordoliani F, et al: Pathogenesis and treatment of xanthomatosis associated with monoclonal gammopathy. Blood. 118:3777–3784. 2011. View Article : Google Scholar : PubMed/NCBI | |
Dagistan E, Canan A, Kizildag B and Barut AY: Multiple tendon xanthomas in patient with heterozygous familial hypercholesterolaemia: Sonographic and MRI findings. BMJ Case Rep 2013. 2013. | |
Cruz PD Jr, East C and Bergstresser PR: Dermal, subcutaneous and tendon xanthomas: Diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol. 19:95–111. 1988. View Article : Google Scholar : PubMed/NCBI | |
Courtice FC: Permeability of normal and injured skin capillaries to lipoproteins in the rabbit. Aust J Exp Biol Med Sci. 37:451–463. 1959. View Article : Google Scholar : PubMed/NCBI | |
Courtice FC: The transfer of proteins and lipids from plasma to lymph in the leg of the normal and hypercholesterolaemic rabbit. J Physiol. 155:456–469. 1961. View Article : Google Scholar : PubMed/NCBI | |
Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M and Civeira F: Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 579:4503–4512. 2005. View Article : Google Scholar : PubMed/NCBI | |
Perrone G, Zagami M, Casale M, Salvinelli F, Morini S and Rabitti C: Immunohistochemistry and differential diagnosis of a solitary flat laryngeal xanthoma: A case report. In Vivo. 21:119–121. 2007.PubMed/NCBI | |
Bureau NJ and Roederer G: Sonography of achilles tendon xanthomas in patients with heterozygous familial hypercholesterolemia. AJR Am J Roentgenol. 171:745–749. 1998. View Article : Google Scholar : PubMed/NCBI | |
Bude RO, Adler RS and Bassett DR: Diagnosis of achilles tendon xanthoma in patients with heterozygous familial hypercholesterolemia: MR vs. sonography. AJR Am J Roentgenol. 162:913–917. 1994. View Article : Google Scholar : PubMed/NCBI | |
Liem MS, Leuven JA, Bloem JL and Schipper J: Magnetic resonance imaging of achilles tendon xanthomas in familial hypercholesterolemia. Skeletal Radiol. 21:453–457. 1992. View Article : Google Scholar : PubMed/NCBI | |
Yamashita S, Hbujo H, Arai H, Harada-Shiba M, Matsui S, Fukushima M, Saito Y, Kita T and Matsuzawa Y: Long-term probucol treatment prevents secondary cardiovascular events: A cohort study of patients with heterozygous familial hypercholesterolemia in Japan. J Atheroscler Thromb. 15:292–303. 2008. View Article : Google Scholar : PubMed/NCBI | |
Civeira F, Castillo S, Alonso R, Meriño-Ibarra E, Cenarro A, Artied M, Martín-Fuentes P, Ros E, Pocoví M and Mata P: Spanish Familial Hypercholesterolemia Group: Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation. Arterioscler Thromb Vasc Biol. 25:1960–1965. 2005. View Article : Google Scholar : PubMed/NCBI | |
Bots ML, Hoes AW, Koudstaal PJ, Hofman A and Grobbee DE: Common carotid intima-media thickness and risk of stroke and myocardial infarction: The rotterdam study. Circulation. 96:1432–1437. 1997. View Article : Google Scholar : PubMed/NCBI | |
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR and Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The atherosclerosis risk in communities (ARIC) study, 1987–1993. Am J Epidemiol. 146:483–494. 1997. View Article : Google Scholar : PubMed/NCBI | |
Beigel R and Beigel Y: Homozygous familial hypercholesterolemia: long term clinical course and plasma exchange therapy for two individual patients and review of the literature. J Clin Apher. 24:219–224. 2009. View Article : Google Scholar : PubMed/NCBI | |
Selvan JP, Uthaman B, Abushaban L and Jebaraj R: Homozygous familial hypercholesterolemia with generalized arterial disease. Med Princ Pract. 16:75–78. 2007. View Article : Google Scholar : PubMed/NCBI | |
Rader DJ, Cohen J and Hobbs HH: Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest. 111:1795–1803. 2003. View Article : Google Scholar : PubMed/NCBI | |
Ahn JH, Chun TJ and Lee S: Nodular excision for painful localized achilles tendon xanthomas in type II hyperlipoproteinemia: A case report. J Foot Ankle Surg. 50:603–606. 2011. View Article : Google Scholar : PubMed/NCBI | |
Moroney PJ and Besse JL: Resection of bilateral massive achilles tendon xanthomata with reconstruction using a flexor hallucis longus tendon transfer and bosworth turndown flap: A case report and literature review. Foot Ankle Surg. 18:e25–e28. 2012. View Article : Google Scholar : PubMed/NCBI | |
Fahey JJ, Stark HH, Donovan WF and Drennan DB: Xanthoma of the achilles tendon. Seven cases with familial hyperbetalipoproteinemia. J Bone Joint Surg Am. 55:1197–1211. 1973. View Article : Google Scholar : PubMed/NCBI |